Vanda Pharmaceuticals Income Statement
- Quarterly: December 2012 - September 2010 Previous Quarters
- Annual
| Income | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| Revenue | 7.920M | 8.288M | 8.378M | 8.141M | 8.370M | 7.969M | 7.430M | 7.501M | 7.752M | 7.246M |
| Cost of Goods Sold | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 7.791M | 8.288M | 8.378M | 8.141M | 8.370M | 7.969M | 7.430M | 7.501M | 7.752M | 7.246M |
| Depreciation Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Amortization Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Depreciation, Amortization, Depletion Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| R&D Expense | 10.62M | 10.16M | 12.49M | 12.18M | 10.56M | 8.174M | 5.999M | 4.267M | 3.822M | 4.072M |
| G&A Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| SG&A Expense | 3.225M | 3.147M | 3.601M | 3.909M | 3.345M | 2.711M | 2.572M | 2.858M | 2.762M | 2.054M |
| Total Operating Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non Operating Interest Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Non-Operating Int Exp | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Income and Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pre-Tax Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Income from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Income | -6.369M | -5.326M | -8.007M | -7.962M | -5.523M | -3.074M | -1.341M | 0.1360M | 2.199M | 3.184M |
| Basic EPS | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| EPS Basic from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Basic | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Diluted EPS | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| EPS Diluted from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Diluted | -0.2256 | -0.1900 | -0.2800 | -0.2800 | -0.1965 | -0.1100 | -0.0500 | 0.00 | 0.0762 | 0.1100 |
| Shares Data | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| Average Basic Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Diluted Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
